Handula M - Search Results

1

First preclinical evaluation of [²²⁵Ac]Ac-DOTA-JR11 and comparison with [¹⁷⁷Lu]Lu-DOTA-JR11, alpha versus beta radionuclide therapy of NETs.

Handula M, Beekman S, Konijnenberg M, Stuurman D, de Ridder C, Bruchertseifer F, Morgenstern A, Denkova A, de Blois E, Seimbille Y. Handula M, et al. EJNMMI Radiopharm Chem. 2023 Jun 30;8(1):13. doi: 10.1186/s41181-023-00197-0. EJNMMI Radiopharm Chem. 2023. PMID: 37389800 Free PMC article.

2

Synthesis and Evaluation of Two Long-Acting SSTR2 Antagonists for Radionuclide Therapy of Neuroendocrine Tumors.

Koustoulidou S, Handula M, de Ridder C, Stuurman D, Beekman S, de Jong M, Nonnekens J, Seimbille Y. Koustoulidou S, et al. Among authors: handula m. Pharmaceuticals (Basel). 2022 Sep 16;15(9):1155. doi: 10.3390/ph15091155. Pharmaceuticals (Basel). 2022. PMID: 36145375 Free PMC article.

3

Pre- and Intraoperative Visualization of GRPR-Expressing Solid Tumors: Preclinical Profiling of Novel Dual-Modality Probes for Nuclear and Fluorescence Imaging.

Verhoeven M, Handula M, van den Brink L, de Ridder CMA, Stuurman DC, Seimbille Y, Dalm SU. Verhoeven M, et al. Among authors: handula m. Cancers (Basel). 2023 Apr 5;15(7):2161. doi: 10.3390/cancers15072161. Cancers (Basel). 2023. PMID: 37046825 Free PMC article.

4

Preclinical Evaluation of a PSMA-Targeting Homodimer with an Optimized Linker for Imaging of Prostate Cancer.

Murce E, Beekman S, Spaan E, Handula M, Stuurman D, de Ridder C, Seimbille Y. Murce E, et al. Among authors: handula m. Molecules. 2023 May 11;28(10):4022. doi: 10.3390/molecules28104022. Molecules. 2023. PMID: 37241763 Free PMC article.

5

Radiochemical and Biological Evaluation of 3p-C-NETA-ePSMA-16, a Promising PSMA-Targeting Agent for Radiotheranostics.

Murce E, Ahenkorah S, Beekman S, Handula M, Stuurman D, de Ridder C, Cleeren F, Seimbille Y. Murce E, et al. Among authors: handula m. Pharmaceuticals (Basel). 2023 Jun 15;16(6):882. doi: 10.3390/ph16060882. Pharmaceuticals (Basel). 2023. PMID: 37375829 Free PMC article.

6

IEDDA: An Attractive Bioorthogonal Reaction for Biomedical Applications.

Handula M, Chen KT, Seimbille Y. Handula M, et al. Molecules. 2021 Jul 30;26(15):4640. doi: 10.3390/molecules26154640. Molecules. 2021. PMID: 34361793 Free PMC article. Review.

7

A novel clickable MSAP agent for dual fluorescence/nuclear labeling of biovectors.

Chen KT, Nieuwenhuizen J, Handula M, Seimbille Y. Chen KT, et al. Among authors: handula m. Org Biomol Chem. 2020 Aug 12;18(31):6134-6139. doi: 10.1039/d0ob01222j. Org Biomol Chem. 2020. PMID: 32724970

8

Towards Complete Tumor Resection: Novel Dual-Modality Probes for Improved Image-Guided Surgery of GRPR-Expressing Prostate Cancer.

Handula M, Verhoeven M, Chen KT, Haeck J, de Jong M, Dalm SU, Seimbille Y. Handula M, et al. Pharmaceutics. 2022 Jan 14;14(1):195. doi: 10.3390/pharmaceutics14010195. Pharmaceutics. 2022. PMID: 35057090 Free PMC article.

9

A Novel Luciferase-Based Reporter Gene Technology for Simultaneous Optical and Radionuclide Imaging of Cells.

Gaspar N, Handula M, Stroet MCM, Marella-Panth K, Haeck J, Kirkland TA, Hall MP, Encell LP, Dalm S, Lowik C, Seimbille Y, Mezzanotte L. Gaspar N, et al. Among authors: handula m. Int J Mol Sci. 2024 Jul 27;25(15):8206. doi: 10.3390/ijms25158206. Int J Mol Sci. 2024. PMID: 39125775 Free PMC article.

10

eTFC-01: a dual-labeled chelate-bridged tracer for SSTR2-positive tumors.

Chapeau D, Beekman S, Handula M, Murce E, de Ridder C, Stuurman D, Seimbille Y. Chapeau D, et al. Among authors: handula m. EJNMMI Radiopharm Chem. 2024 May 22;9(1):44. doi: 10.1186/s41181-024-00272-0. EJNMMI Radiopharm Chem. 2024. PMID: 38775990 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters